taurine has been researched along with Hematologic Diseases in 2 studies
Hematologic Diseases: Disorders of the blood and blood forming tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighty-four patients with refractory cancer received 12 dose escalations from 10-150 mg/m2 TCNU administered orally every 6 weeks." | 1.27 | Phase I study of TCNU, a novel nitrosourea. ( Cornbleet, MA; Kerr, ME; Leonard, RC; Macpherson, JS; Smyth, JF; Warrington, PS; Whelan, JM, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vibe-Petersen, J | 1 |
| Bork, E | 1 |
| Møller, H | 1 |
| Hansen, HH | 1 |
| Smyth, JF | 1 |
| Macpherson, JS | 1 |
| Warrington, PS | 1 |
| Kerr, ME | 1 |
| Whelan, JM | 1 |
| Cornbleet, MA | 1 |
| Leonard, RC | 1 |
2 other studies available for taurine and Hematologic Diseases
| Article | Year |
|---|---|
A phase I clinical evaluation of 1-(2-chloroethyl)-3-[2-(dimethylaminosulphonyl)ethyl]-1-nitrosou rea (TCNU).
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Evaluation; H | 1987 |
Phase I study of TCNU, a novel nitrosourea.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Evaluation; F | 1987 |